@kanvgarg123
It’s been brewing and bubbling for some time now. Management increased R&D spends and cap ex plans towards the same and last 2 concalls spoke about focus on agro and pharma specialty chem. Linking you to the discussion we had in the deepak thread a few months ago. The discussion there along with the previous concall notes will help. Spec chem was the basis of my investment thesis due to the high margins on offer hence leading to a re rating and that seems to be playing out perfectly. There’ll be a quarter over the next year when everything will fire on all cylinders(basic , performance, spec and phenol) and the EPS will go through the roof.
Deepak Nitrite
2 Likes